publication date: Dec. 26, 2010

In this issue: 

Advisors Approve NCI Plan To Contract For Early Clinical Trials Of Imaging Agents.

NCI Recruits Carl Barrett Of NIEHS To Direct Basic Sciences; Freedman named to NCAB.

Sieber Direct Communications At NCI, Reorganizing Offices.

“5 A Day” Review Underway to Check Program’s Health at NCI.

AACR Honors Nine Cancer Researchers, Clinicians.

Cytogen Corp.’s Imaging Agent ProstaScint Added to NCCN Prostate Cancer Guidelines.

FDA Grants Six-Month Priority Review To Nolvadex For DCIS Adjuvant Treatment.

Bristol-Myers, Karolinska In Collaboration For Studies.

Antigenics Begins Phase II Trial Of Oncophage for NHL.

Aphton To Test Anti-Gastrin Drug At M. D. Anderson. NAS

RFP: Intellectual Property.

Download (PDF 413KB)

To access this members-only content, please log in.
Institutional subscribers, please log in with your IP.
If you're not a subscriber why not join today?
To gain access to the members only content click here to subscribe.
You will be given immediate access to premium content on the site.
Click here to join.

Copyright (c) 2020 The Cancer Letter Inc.